Rhythm Pharmaceuticals buy Canaccord Genuity Group Inc.
Start price
02.03.23
/
50%
€21.20
Target price
02.03.24
€52.93
Performance (%)
85.85%
End price
03.03.24
€39.40
Summary
This prediction ended on 03.03.24 with a price of €39.40. The BUY prediction by Canaccord_Genuity_Gr for Rhythm Pharmaceuticals saw massive gains of 85.85%. Canaccord_Genuity_Gr has a follow-up prediction for Rhythm Pharmaceuticals where he still thinks Rhythm Pharmaceuticals is a Buy. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Rhythm Pharmaceuticals | 18.116% | 18.116% | 44.248% | 450.676% |
| iShares Core DAX® | 0,22 % | 1,49 % | 3,58 % | 50,28 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % | 39,14 % | 107,46 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % | 50,96 % | 76,35 % |
| iShares S&P 500 | 2,17 % | 8,06 % | 25,62 % | 72,62 % |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at Canaccord Genuity Group Inc. from $52.00 to $56.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
In the thread Trading Rhythm Pharmaceuticals
Die von Canaccord_Genuity_Gr gewählte maximale Laufzeit wurde überschritten
Current prediction by Canaccord_Genuity_Gr for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€81.50
02.03.26
02.03.26
€118.79
02.03.27
02.03.27
-1.84%
08.05.26
08.05.26
